F
X.-X. Shang et al.
Paper
Synthesis
2-(4-Chlorophenyl)-4H-benzo[d][1,3]oxazin-4-one (2m)11
1H NMR (400 MHz, CDCl3): δ = 9.48 (s, 1 H), 8.77 (d, J = 7.6 Hz, 1 H),
8.53 (d, J = 7.6 Hz, 1 H), 8.24 (d, J = 8.0 Hz, 1 H), 7.85–7.81 (t, J = 8.0 Hz,
1 H), 7.70 (d, J = 8.0 Hz, 1 H), 7.55–7.51 (t, J = 7.6 Hz, 1 H), 7.45–7.42
(dd, J = 8.0, 4.8 Hz, 1 H).
Yield: 167 mg (65%); colorless needles; mp 181–182 °C.
1H NMR (400 MHz, CDCl3): δ = 8.23–8.21 (m, 3 H), 7.83–7.79 (m, 1 H),
7.67 (d, J = 8.0Hz, 1 H), 7.53–7.45 (m, 3 H).
ESI-MS: m/z [M + H]+ calcd for C13H8N2O2: 225.06; found: 225.09.
ESI-MS: m/z [M + H]+ calcd for C14H8ClNO2: 258.02; found: 258.05.
2-Phenyl-3H-indol-3-one (3a)11
2-(4-Bromophenyl)-4H-benzo[d][1,3]oxazin-4-one (2n)11
Yield: 17 mg (8%); red solid; mp 96–97 °C.
1H NMR (400 MHz, CDCl3): δ = 8.36 (d, J = 7.6 Hz, 2 H), 7.54–7.45 (m, 5
H), 7.40 (d, J = 7.6 Hz, 1 H), 7.26 (t, J = 7.6 Hz, 1 H).
Yield: 208 mg (69%); colorless needles; mp 179–180 °C.
1H NMR (400 MHz, CDCl3): δ = 8.23 (d, J = 7.6 Hz, 1 H), 8.16 (d, J = 8.0
Hz, 2 H), 7.83–7.19 (t, J = 6.8 Hz, 1 H), 7.67–7.62 (m, 3 H), 7.53–7.49 (t,
J = 7.2 Hz, 1 H).
ESI-MS: m/z [M + H]+ calcd for C14H9NO: 208.07; found: 208.05.
ESI-MS: m/z [M + H]+ calcd for C14H8BrNO2: 301.97; found: 302.00.
Funding Information
2-[4-(Trifluoromethyl)phenyl]-4H-benzo[d][1,3]oxazin-4-one
(2o)8
This work was supported by grants from the National Standardization
Project of Traditional Chinese Medicine (No. ZYBZH-Y-JX-27) and Fun-
damental Research Funds for the Central Universities (No. FRF-BR-14-
Yield: 218 mg (75%); colorless needles; mp 90–91 °C.
1H NMR (400 MHz, CDCl3): δ = 8.42 (d, J = 8.4 Hz, 2 H), 8.25 (d, J = 8.0
Hz, 1 H), 7.86–7.82 (t, J = 8 Hz, 1 H), 7.76 (d, J = 8.4, 2 H), 7.71 (d, J = 8
Hz, 1 H), 7.56–7.53 (t, J = 7.6 Hz, 1 H).
002A).
N
oaitn
a
l
S
at
n
d
ardzoaitn
Proejct
of
Traoditni
a
l
C
h
n
i
ese
M
e
d
nc
i
e
Z(
Y
B
Z
H
YX-J-2
7
F)u
n
d
a
m
e
n
atl
Reseacrh
F
u
n
ds
o
f
r
hte
C
e
nrta
l
Unveitrsi
F(
R
F-BR-14-0
0
2
A)
ESI-MS: m/z [M + H]+ calcd for C15H8F3NO2: 292.05; found: 292.09.
Acknowledgment
2-(1,1′-Biphenyl-4-yl)-4H-benzo[d][1,3]oxazin-4-one (2p)11
We thank Prof. Dr. Chun-An Fan from Lanzhou University for helpful
discussions and great suggestions.
Yield: 158 mg (53%); colorless needles; mp 138–139 °C.
1H NMR (400 MHz, CDCl3): δ = 8.37 (d, J = 8.4 Hz, 2 H), 8.23 (d, J = 7.6
Hz, 1 H), 7.84–7.80 (t, J = 8.0 Hz, 1 H), 7.73–7.64 (m, 5 H), 7.52–7.37
(m, 4 H).
Supporting Information
ESI-MS: m/z [M + H]+ calcd for C20H13NO2: 300.09; found: 300.16.
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
o
nrtogI
f
rmoaitn
2-(3-Methoxyphenyl)-4H-benzo[d][1,3]oxazin-4-one (2q)11
Yield: 157 mg (62%); colorless needles; mp 117–118 °C.
References
1H NMR (400 MHz, CDCl3): δ = 8.23 (d, J = 8.0 Hz, 1 H), 7.90 (d, J = 7.6
Hz, 1 H), 7.83–7.80 (m, 2 H), 7.69 (d, J = 8.0 Hz, 1 H), 7.52–7.48 (t, J =
7.6 Hz, 1 H), 7.41–7.37 (t, J = 8.0 Hz, 1 H), 7.11–7.09 (dd, J = 0.2, 6.4 Hz,
1 H), 3.89 (s, 3 H).
(1) Fenton, G.; Newton, C. G.; Wyman, B. M.; Bagge, P.; Dron, D. I.;
Riddell, D.; Jones, G. D. J. Med. Chem. 1989, 32, 265.
(2) Hadfield, J. A.; Pavlidis, V. H.; McGown, A. T.; Whitworth, C.;
Perry, P. J.; Fox, B. W. Anti-Cancer Drugs 1994, 5, 533.
(3) Hays, S. J.; Caprathe, B. W.; Gilmore, J. L.; Amin, N.; Emmerling,
M. R.; Michael, W.; Nadimpalli, R.; Nath, R.; Raser, K. J.; Stafford,
D.; Watson, D.; Wang, K.; Jaen, J. C. J. Med. Chem. 1998, 41, 1060.
(4) Kumar, P.; Shrivastava, B.; Pandeya, S. N.; Stables, J. P. Eur. J. Med.
Chem. 2011, 46, 1006.
(5) (a) Larksarp, C.; Alper, H. Org. Lett. 1999, 1, 1619. (b) Wu, X.-F.;
Schranck, J.; Neumann, H.; Beller, M. Chem. Eur. J. 2011, 17,
12246. (c) Wu, X.-F.; Neumann, H.; Beller, M. Chem. Eur. J. 2012,
18, 12599.
ESI-MS: m/z [M + H]+ calcd for C15H11NO3: 254.07; found: 254.09.
2-(3,4-Dimethylphenyl)-4H-benzo[d][1,3]oxazin-4-one (2r)11
Yield: 161 mg (64%); colorless needles; mp 144–145 °C.
1H NMR (400 MHz, DMSO-d6): δ = 8.12 (d, J = 7.6 Hz, 1 H), 7.94–7.88
(m, 3 H), 7.68 (d, J = 8 Hz, 1 H), 7.60–7.56 (t, J = 7.6 Hz, 1 H), 7.33 (d, J =
8.0 Hz, 1 H), 2.30 (s, 3 H), 2.29 (s, 3 H).
ESI-MS: m/z [M + H]+ calcd for C16H13NO2: 252.09; found: 252.11.
(6) Giri, R.; Lam, J. K.; Yu, J.-Q. J. Am. Chem. Soc. 2010, 132, 686.
(7) Houlden, C. E.; Hutchby, M.; Bailey, C. D.; Ford, J. G.; Tyler, S. N.;
Gagne, M. R.; Lloyd-Jones, G. C.; Booker-Milburn, K. I. Angew.
Chem. Int. Ed. 2009, 48, 1830.
(8) Liu, Q.; Chen, P.; Liu, G. ACS Catal. 2013, 3, 178.
(9) Ge, Z.-Y.; Xu, Q.-M.; Fei, X.-D.; Tang, T.; Zhu, Y.-M.; Ji, S.-J. J. Org.
Chem. 2013, 78, 4524.
2-(4-Pyridyl)-4H-benzo[d][1,3]oxazin-4-one (2s)11
Yield: 112 mg (50%); white solid; mp 161–162 °C.
1H NMR (400 MHz, CDCl3): δ = 8.81 (d, J = 5.2 Hz, 2 H), 8.26 (d, J = 7.6
Hz, 1 H), 8.11 (d, J = 5.6 Hz, 2 H), 7.87–7.83 (m, 1 H), 7.73 (d, J = 8.0 Hz,
1 H), 7.59–7.55 (t, J = 7.6 Hz, 1 H).
ESI-MS: m/z [M + H]+ calcd for C13H8N2O2: 225.06; found: 225.1.
(10) Yamashita, M.; Iida, A. Tetrahedron 2014, 70, 5746.
(11) Lian, X.-L.; Lei, H.; Quan, X.-J.; Ren, Z.-H.; Wang, Y.-Y.; Guan, Z.-
H. Chem. Commun. 2013, 49, 8196.
(12) (a) Yamashita, M.; Iida, A. Tetrahedron Lett. 2014, 55, 2991.
(b) Feng, Y. D.; Li, Y. D.; Cheng, G. L.; Wang, L. H.; Cui, X. L. J. Org.
Chem. 2015, 80, 7099. (c) Yamashita, M.; Nishizono, Y.;
Himekawa, S.; Iida, A. Tetrahedron 2016, 72, 4123.
2-(3-Pyridyl)-4H-benzo[d][1,3]oxazin-4-one (2t)25
Yield: 143 mg (64%); white solid; mp 129–130 °C.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2017, 49, A–G